Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT CD22 binding agent Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia 2 D007938 ClinicalTrials
Leukemia, Hairy Cell 2 D007943 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109352